Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
作者信息
Cirkel U, Schweppe K W, Ochs H, Schneider H P
出版信息
Prog Clin Biol Res. 1986;225:189-99.
PMID:3097665
Abstract
摘要
相似文献
1
Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).促性腺激素释放激素激动剂疗法在子宫内膜异位症治疗中的作用（德国经验）。
Prog Clin Biol Res. 1986;225:189-99.
2
The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).促黄体生成素释放激素激动剂疗法治疗子宫内膜异位症的效果（荷兰的经验）
Prog Clin Biol Res. 1986;225:201-10.
3
Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
Prog Clin Biol Res. 1986;225:211-25.
4
5
CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
Acta Eur Fertil. 1992 Jul-Aug;23(4):171-4.
6
[Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
Geburtshilfe Frauenheilkd. 1986 Aug;46(8):483-9. doi: 10.1055/s-2008-1036242.
7
[Hormonal changes in buserelin therapy].
Zentralbl Gynakol. 1989;111(18):1236-40.
8
9
[Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
Geburtshilfe Frauenheilkd. 1994 Oct;54(10):569-73. doi: 10.1055/s-2007-1022341.
10
Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
Clin Reprod Fertil. 1986 Oct;4(5):329-36.
引用本文的文献
1
Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.布舍瑞林。对其药效学和药代动力学特性以及临床概况的综述。
Drugs. 1990 Mar;39(3):399-437. doi: 10.2165/00003495-199039030-00007.
Zotero 插件